Sfoglia per AUTORE
LU S
Collezione ASL Torino 4

  

Items : 1

SKYSCRAPER-02: Primary results of a phase III, randomized, double-blind, placebocontrolled study of atezolizumab (atezo) + carboplatin + etoposide (CE) with or without tiragolumab (tira) in patients (pts) with untreated extensive-stage small cell lung cancer (ES-SCLC) in Journal of Clinical Oncology

2022
ASL Torino 4

Rudin CM; Liu SV; Lu S; Soo RA; Hong MH; Lee J-S; Bryl M; Dumoulin DW; Rittmeyer A; Chiu C-H; Ozyilkan O; Navarro A; Novello S; Ozawa Y; Meng R; Hoang T; Lee A; Wen X; Huang M; Reck M;